2006•The Journal of Clinical PsychiatryRequires access

Effect of aripiprazole on quality of life of schizophrenic patients

Wang Gang-pin

Abstract

Objective:To compare the effect of aripiprazole and risperidone on quality of life of schizophrenic patients. Method:Schizophrenic patients who were treated by aripiprazole (n=30) or risperidone (n=30) were evaluated with general quality of life inventory (GQOLI-74),positive and negative symptom scale (PANSS) and treatment emergent symptom scale (TESS) for 8 weeks. Results:The quality of life were improved in the schizophrenic patients who treated with aripiprazole or risperidone.There was significant difference in GQOLI-74 between two groups.Aripiprazole was significantly better than risperidone. Conclusion:Aripiprazole is beneficial to improve the quality of life in schizophrenic patients.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Aripiprazole, Risperidone, Quality of life (healthcare), Schizophrenia (object-oriented programming), Psychology, Psychiatry, Significant difference, Medicine